LINCOLN PHARMACEUTICALS LTD. | Scrip Code : 531633 | Quarter ending :September 2017 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 32 | 66,36,015 | 66,36,015 | 33.18 | 66,36,015 | 33.18 | 8,00,000 | 12.06 | 66,36,015 | - | - | - | (B) Public | 15,619 | 1,33,63,985 | 1,33,63,985 | 66.82 | 1,33,63,985 | 66.82 | 28,89,200 | 21.62 | 1,27,71,175 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 15,651 | 2,00,00,000 | 2,00,00,000 | 100.00 | 2,00,00,000 | 100.00 | 36,89,200 | 18.45 | 1,94,07,190 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|